Please use this identifier to cite or link to this item:
Title: Early Surgery after Coronary Revascularization: A Fine Line between Bleeding and Thrombosis
Authors: De Biase, Chiara
Capuano, Ernesto
De Luca, Stefania
D’Anna, Carolina
Luciano, Rossella
Piscione, Federico
Trimarco, Bruno
Galasso, Gennaro
Keywords: Non-cardiac surgery
Percutaneous coronary intervention
Antiplatelet therapy
Stent hrombosis
Issue Date: 2015
Citation: De Biase C, Capuano E, De Luca S, D’Anna C, Luciano R, Piscione F, Trimarco B, Galasso G. Early Surgery after Coronary Revascularization: A Fine Line between Bleeding and Thrombosis. Translational Medicine @ UniSa 2015, 11(3):14-23
Abstract: Management of PCI patients undergoing early surgery is still a matter of debate. Noteworthy, PCI patients require a dual antiplatelet therapy (DAPT), with aspirine and a thienopiridine (clopidogrel, prasugrel, ticagrelor), because of the high risk of stent thrombosis (ST), myocardial infarction (MI) and death, especially within the first month. Indeed, the number of surgical interventions after PCI is actually increasing, and physicians are looking for the best antiplatelet therapy management, in order to reduce both, bleeding and thrombosis risk. In this paper, current guidelines therapy management and new optional strategies to reduce the cardiovascular risk, related to early surgery, are discussed.
ISSN: 2239-9747
Appears in Collections:Translational Medicine @ UniSa. Volume 11 (jan.-apr. 2015)

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.